As previously reported and observed in the current study, optic atrophy and retinal dystrophy are the major clinical features recognized in patients harboring SSBP1 variants with RGC, photoreceptors and RPE being the site of highest SSBP1 expression.8 The gene discussed is SSBP1; the disease is optic atrophy.